404 related articles for article (PubMed ID: 6131922)
21. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
Webster RO; Goldstein IM; Flick MR
J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
[TBL] [Abstract][Full Text] [Related]
22. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
Beswick PH; Kay AB
Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
[TBL] [Abstract][Full Text] [Related]
23. Granulocytes without degranulation: neutrophil function in granule-depleted neutroplasts.
Korchak HM; Roos D; Giedd KN; Wynkoop EM; Vienne K; Rutherford LE; Buyon JP; Rich AM; Weissmann G
Trans Assoc Am Physicians; 1983; 96():356-64. PubMed ID: 6093314
[TBL] [Abstract][Full Text] [Related]
24. Activation of monocytes by interferon-gamma has no effect on the level or affinity of the nicotinamide adenine dinucleotide-phosphate oxidase and on agonist-dependent superoxide formation.
Thelen M; Wolf M; Baggiolini M
J Clin Invest; 1988 Jun; 81(6):1889-95. PubMed ID: 2838524
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
Harvath L; McCall CE; Bass DA; McPhail LC
J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
[TBL] [Abstract][Full Text] [Related]
26. Chemotaxis, spreanding nd oxidative metabolism of neutrophils: influence of albumin in vitro.
Valerius NH
Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):43-9. PubMed ID: 6306991
[TBL] [Abstract][Full Text] [Related]
27. Central effects of histamine and H1 and H2 receptors agonists and antagonists after intraventricular infusion in fowls.
Nisticò G; Rotiroti D; De Sarro A; Naccari F; Stephenson JD
Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):431-50. PubMed ID: 6104348
[TBL] [Abstract][Full Text] [Related]
28. Eosinophil chemotaxis and anterior uveitis from topical dimaprit and nordimaprit.
Mindel JS; Friedman AH; Haimov T; Kharlamb AB; Freilich JM
Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1504-11. PubMed ID: 2944854
[TBL] [Abstract][Full Text] [Related]
29. The effect of histamine, H1 and H2 agonists, and H1 and H2 antagonists on postprandial pancreatic polypeptide release in dogs.
Linnestad P; Guldvog I; Schrumpf E
Scand J Gastroenterol; 1983 Mar; 18(2):165-8. PubMed ID: 6143392
[TBL] [Abstract][Full Text] [Related]
30. Histamine excites neonatal rat sympathetic preganglionic neurons in vitro via activation of H1 receptors.
Whyment AD; Blanks AM; Lee K; Renaud LP; Spanswick D
J Neurophysiol; 2006 Apr; 95(4):2492-500. PubMed ID: 16354729
[TBL] [Abstract][Full Text] [Related]
31. A monoclonal antibody inhibiting human neutrophil chemotaxis and degranulation.
Cotter TG; Spears P; Henson PM
J Immunol; 1981 Oct; 127(4):1355-60. PubMed ID: 6268706
[TBL] [Abstract][Full Text] [Related]
32. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors.
Elenkov IJ; Webster E; Papanicolaou DA; Fleisher TA; Chrousos GP; Wilder RL
J Immunol; 1998 Sep; 161(5):2586-93. PubMed ID: 9725260
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of phytohaemagglutinin-induced proliferation of human peripheral blood lymphocytes by histamine and histamine H1 and H2 agonists.
Badger AM; Young J; Poste G
Clin Exp Immunol; 1983 Jan; 51(1):178-84. PubMed ID: 6219840
[TBL] [Abstract][Full Text] [Related]
34. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
Mackin WM; Huang CK; Becker EL
J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
[TBL] [Abstract][Full Text] [Related]
35. Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH.
Selvatici R; Falzarano S; Franceschetti L; Mollica A; Guerrini R; Siniscalchi A; Spisani S
FEBS J; 2008 Feb; 275(3):449-57. PubMed ID: 18167144
[TBL] [Abstract][Full Text] [Related]
36. Possible role of histamine receptors in the central regulation of immune responses.
Moharana AK; Bhattacharya SK; Mediratta PK; Sharma KK
Indian J Physiol Pharmacol; 2000 Apr; 44(2):153-60. PubMed ID: 10846628
[TBL] [Abstract][Full Text] [Related]
37. Effects of leukotrienes and f-Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils.
Palmblad J; Gyllenhammar H; Lindgren JA; Malmsten CL
J Immunol; 1984 Jun; 132(6):3041-5. PubMed ID: 6327816
[TBL] [Abstract][Full Text] [Related]
38. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
Marasco WA; Showell HJ; Freer RJ; Becker EL
J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
[TBL] [Abstract][Full Text] [Related]
39. Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors.
Burde R; Seifert R; Buschauer A; Schultz G
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):671-8. PubMed ID: 2559336
[TBL] [Abstract][Full Text] [Related]
40. Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187.
Becker EL; Sigman M; Oliver JM
Am J Pathol; 1979 Apr; 95(1):81-97. PubMed ID: 219701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
